Overview

Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy

Status:
Not yet recruiting
Trial end date:
2023-12-31
Target enrollment:
0
Participant gender:
All
Summary
This study aims to investigate the efficacy and safety of bromfenac sodium hydrate eye drops in patients with familial exudative vitreoretinopathy receiving diode laser photocoagulation.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Bromfenac
Criteria
Inclusion Criteria:

- Newly diagnosed patients with familial exudative vitreoretinopathy

- Needing diode laser photocoagulation

- Consent to the study

Exclusion Criteria:

- History of corneal diseases

- History of hypersensitivity to bromfenac sodium

- History of hypersensitivity to non-steroidal anti-inflammatory drugs

- Progressive ocular infection

- Liver diseases

- Hypersensitivity to sulfur dioxide

- Receiving anti-coagulation drugs

- History of coagulopathies